Deborah J. Andrews
Direttore/Membro del Consiglio presso LINEAGE CELL THERAPEUTICS, INC.
Patrimonio netto: 17 292 $ in data 30/04/2024
Profilo
Deborah J.
Andrews is an Independent Director at Lineage Cell Therapeutics, Inc. since 2014.
She was the Chief Financial Officer at STAAR Surgical Co. from 2017 to 2020.
Prior to that, she worked as an Auditor at KPMG Peat Marwick LLP from 1991 to 1994, and as an Internal Auditor at Bourns, Inc. from 1994 to 1995.
She also served as the Vice President-Finance at STAAR Surgical AG in 2001.
Andrews completed her undergraduate degree from California State University-San Bernardino.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
20/07/2023 | 15 578 ( 0.01% ) | 17 292 $ | 30/04/2024 |
Posizioni attive di Deborah J. Andrews
Società | Posizione | Inizio |
---|---|---|
LINEAGE CELL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/04/2014 |
Precedenti posizioni note di Deborah J. Andrews
Società | Posizione | Fine |
---|---|---|
STAAR SURGICAL COMPANY | Direttore Finanziario/CFO | 06/07/2020 |
STAAR Surgical AG
STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The private company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Direttore Finanziario/CFO | 01/01/2001 |
Bourns, Inc.
Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Comptroller/Controller/Auditor | 01/01/1995 |
KPMG Peat Marwick LLP | Comptroller/Controller/Auditor | 01/01/1994 |
Formazione di Deborah J. Andrews
California State University-San Bernardino | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
STAAR SURGICAL COMPANY | Health Technology |
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
KPMG Peat Marwick LLP | Commercial Services |
Bourns, Inc.
Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Producer Manufacturing |
STAAR Surgical AG
STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The private company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Health Technology |
- Borsa valori
- Insiders
- Deborah J. Andrews